Moolec is an early-stage food and agricultural biotechnology company developing alternative protein and specialty lipid ingredients through two core technology platforms: molecular farming and precision fermentation. In molecular farming, Moolec engineers crops — primarily soybean and safflower — to express animal-like proteins and oils. Its lead programs are Piggy Sooy, a soybean engineered to produce porcine myoglobin targeting plant-based and hybrid meat applications, and GLASO, a safflower engineered to produce gamma-linolenic acid (GLA) at concentrations well above conventional sources, targeting nutritional supplements and functional foods. In precision fermentation, Moolec's SynBio Powerlabs subsidiary in Finland operates bioreactor facilities and produces Mycofood™, a fungal-based protein ingredient, while also positioning as a CDMO to help other food and biotech companies scale fermentation processes. Moolec operates as a B2B ingredient supplier. Its most mature business is ValoraSoy, an Argentina-based subsidiary that produces and exports textured soy proteins to food manufacturers across more than a dozen countries, providing the primary source of near-term revenue. Moolec also receives royalties from the HB4® climate-smart crop technology licensed to Bioceres Crop Solutions. The company's long-term thesis is that molecular farming can deliver animal-like ingredient functionality at commodity crop cost structures. Moolec is pre-profitability and carries significant financial stress, with management flagging substantial doubt about its ability to continue as a going concern.